Get In Touch
Xeraya Capital Sdn Bhd
26.03–26.08, G Tower
#199 Jalan Tun Razak, KL
xeraya@xeraya.com
+603 2381 8700
Submit a Proposal
proposal@xeraya.com
Back

Portfolio News

Category
Showing 113-128 of 162 results
Filter
July 30, 2020
5 min read

Imago BioSciences Granted Access by European Medicines Agency to PRIME Scheme for IMG-7289 (Bomedemstat) in Myelofibrosis

July 17, 2020
13 min read

Imago Biosciences: Experimental Treatment for Rare Bone Cancer Shows Promise in Phase 2 Study

July 16, 2020
6 min read

GreenLight Biosciences supercharges its efforts with $102M Series D funding from top-tier investors including Morningside Ventures, S2G Ventures and Lupa Systems

June 2, 2020
7 min read

LanzaJet Takes Off: Innovative Sustainable Fuel Technology and Investment Structure to Accelerate Commercialization, Regional Job Growth, and Carbon Reduction

May 27, 2020
5 min read

Rapid Micro Biosystems Raises $120 Million to Accelerate Global Expansion of Contaminant Testing Platform for Pharmaceutical and Vaccine Manufacturing

May 27, 2020
3 min read

Providence Portland Medical Center Begins Patient Treatments with ViewRay's MRIdian Linac

May 26, 2020
3 min read

Partnership to provide catheter-based treatment products for cardiac arrhythmias

May 26, 2020
3 min read

Imago BioSciences To Present Update on Phase 2 results of Bomedemstat (IMG-7289), a Lysine Specific Demethylase-1 (LSD1) Inhibitor for the Treatment of Myelofibrosis (MF)

May 18, 2020
5 min read

Liquidia Appoints Tushar Shah, M.D., as Chief Medical Officer

May 12, 2020
5 min read

GreenLight Biosciences raises $17M financing round to accelerate large-scale manufacturing of future COVID-19 vaccines